News Focus
News Focus
Followers 22
Posts 4065
Boards Moderated 0
Alias Born 10/12/2013

Re: Benny7459 post# 99708

Tuesday, 02/07/2017 12:27:13 PM

Tuesday, February 07, 2017 12:27:13 PM

Post# of 447440

Do you not remember ICPT a few years back.
This stock received trial results and hit 8B MC. This company is still sitting at 2.8B MC and is generating about 20M a year in revenue. This is Biotech!!



Yo, Freak,

So is that what you are basing your investment on? A 1 time pony show!



Plain and simple, "History ...repeat...rhyme."

Ya gotchur fundamentals and your short term stuff and examples are representative of what CAN happen. I don't think Benny bought Amrn and held it based on ICPT and to make that assertion is some what "challenged".

I'm day trading ACAD to rebuild my AMRN position. (Got time to write today, got up late and missed the opening drop) Part of my ACAD thesis is that ACAD soared on buyout speculation when they mysteriously canceled an appearance at a conference. It turned out to be that their plans going forward were in shambles and there was a reorganization and "retirements and time with the family" inna works. The substantial (6 months to a year) extension of the time line and tossing some of the progress already made to date combined with an exchequer that was fading fast took the price from $52 to $16 in 8 months. But I had reason to believe that the problems were fixable. They were and the price has doubled off the bottom.

The $52 was not my thesis. Rather it is a "can happen if" and the "if" is in play. And $52 is some comfort to buying at $16 and $20 and $30 with much better fundamentals. Kinda like the $19 that AMRN saw is NOT the thesis, but makes buying at $0.80 and $1.50 and $3.25 easier. Because some of the "if" is happening.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News